Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 125 for Ovarian

Edit search filters
  1. A Study Of Raludotatug Deruxtecan (R-DXd) In Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Jacksonville, FL

  2. ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  3. Metformin Hydrochloride And Combination Chemotherapy In Treating Patients With Stage III-IV Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

    Rochester, MN

  4. MV-NIS Or Investigator's Choice Chemotherapy In Treating Patients With Ovarian, Fallopian, Or Peritoneal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study To Evaluate The Diagnostic Performance Of GEH300079 (68Ga) Injection PET/CT For Detection Of PC In Patients With Colorectal, Gastric, Ovarian, Or Pancreatic Cancers (PERISCOPE)

    Rochester, MN

  6. PLX038 For The Treatment Of Metastatic Ovarian, Peritoneal, And Fallopian Tube Cancers

    Rochester, MN

  7. Veliparib And Topotecan Hydrochloride In Treating Patients With Solid Tumors, Relapsed Or Refractory Ovarian Cancer, Or Primary Peritoneal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Heated Intraperitoneal Chemotherapy Followed By Niraparib For Ovarian, Primary Peritoneal And Fallopian Tube Cancer (HOTT)

    Rochester, MN

  9. A Study To Compare Letrozole With Or Without Paclitaxel And Carboplatin In Treating Patients With Stage II-IV Ovarian Or Primary Peritoneal Cancer

    Albert Lea, MN, Rochester, MN

  10. Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer. (PROTA)

    Rochester, MN

.

Mayo Clinic Footer